Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis

Diseases of the Esophagus

Volumn 30, Issue 1, 2017, Pages 1-9

  Tan, Deli ^a   Wu, Yuanyuan ^b   Hu, Liwen ^a   He, Ping ^a   Xiong, Gang ^a   Bai, Yun ^b   Yang, Kang ^a  

^a SOUTHWEST HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal squamous cell carcinoma; H19; Long noncoding RNA; Metastasis; Proliferation

Indexed keywords

GELATINASE B; RNA H19; TUMOR MARKER; UVOMORULIN; VIMENTIN; CADHERIN; CDH1 PROTEIN, HUMAN; H19 LONG NON-CODING RNA; LONG UNTRANSLATED RNA; MMP9 PROTEIN, HUMAN;

ADULT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER TISSUE; CELL CYCLE ASSAY; CELL CYCLE G0 PHASE; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EC9706 CELL LINE; ECA-109 CELL LINE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA CELL LINE; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KYSE-150 CELL LINE; KYSE450 CELL LINE; LYMPH NODE METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CANCER TRANSPLANTATION; CELL CYCLE; CELL MOTION; ESOPHAGUS TUMOR; GENETICS; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANIMALS; BLOTTING, WESTERN; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; IN VITRO TECHNIQUES; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; UP-REGULATION; VIMENTIN;

EID: 84973138153     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12481     Document Type: Article

References (43)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cance J Clin 2013; 63: 11-30
2. McLoughlin J M, Lewis J M, Meredith K L. The impact of age on morbidity and mortality following esophagectomy for esophageal cancer. Cancer Control 2013; 20: 144-50
3. Jemal A, Bray F, Center M M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90
4. Feber A, Xi L, Pennathur A et al. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma. Ann Thorac Surg 2011; 91: 1523-30
5. Guo P, Huang Z L, Yu P, Li K. Trends in cancer mortality in China: an update. Ann Oncol 2012; 23: 2755-62
6. Dubecz A, Gall I, Solymosi N et al. Temporal trends in long-term survival and cure rates in esophageal cancer: a seer database analysis. J Thorac Oncol 2012; 7: 443-7
7. Tachibana M, Kinugasa S, Hirahara N, Yoshimura H. Lymph node classification of esophageal squamous cell carcinoma and adenocarcinoma. Eur J Cardiothorac Surg 2008; 34: 427-31
8. Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell 2013; 154: 26-46
9. Spizzo R, Almeida MI, Colombatti A, Calin GA. Long noncoding RNAs and cancer: a new frontier of translational research? Oncogene 2012; 31: 4577-87
10. Matouk I J, Mezan S, Mizrahi A et al. The oncofetal H19 RNA connection: hypoxia, p53 and cancer. Biochim Biophys Acta 2010; 1803: 443-51
11. Prensner J R, Chinnaiyan A M. The emergence of lncRNAs in cancer biology. Cancer Discov 2011; 1: 391-407
12. Gupta R A, Shah N, Wang K C et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-6
13. EstellerM. Non-codingRNAs in human disease. NatRev Genet 2011; 12: 861-74
14. Qiu M T, Hu J W, Yin R, Xu L. Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol 2013; 34: 613-20
15. Gibb E A, Vucic E A, Enfield K S et al. Human cancer long non-coding RNA transcriptomes. PLoS One 2011; 6: e25915
16. Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 2013; 339: 159-66
17. Brannan C I, Dees E C, Ingram R S, Tilghman S M. The product of the H19 gene may function as an RNA. Mol Cell Biol 1990;10:28-36
18. Keniry A, Oxley D, Monnier P et al. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol 2012; 14: 659-65
19. Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J. Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J 2013; 280: 1709-16
20. Berteaux N, Lottin S, Monté D et al. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem 2005; 280: 29625-36
21. Zhang L, Yang F, Yuan J H et al. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis 2013; 34: 577-86
22. Chen C L, Ip S M, Cheng D, Wong L C, Ngan H Y. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer. Clin Cancer Res 2000; 6: 474-9
23. Nakagawa H, Chadwick R B, Peltomaki P et al. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCFbinding sites in colorectal cancer. Proc NatlAcad Sci USA 2001; 98: 591-6
24. Ariel I, Sughayer M, Fellig Y et al. The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol Patho 2000; l53: 320-3
25. Huang C, Cao L, Qiu L et al. Upregulation of H19 promotes invasion and induces epithelial-to-mesenchymal transition in esophageal cancer, Oncol Lett 2015; 10: 291-6
26. Yang Z, Zhou L, Wu L M et al. Overexpression of long noncoding RNA HOTAIR predict tumor recurrence in hepatocellular carcinoma patients follow in liver transplantation. Ann Surg Oncol 2011; 18: 1243-50
27. Nie L, Wu H J, Hsu J M et al. Long non-coding RNAs: versatile master regulators of gen expression and crucial players in cancer. Am J Transl Res 2012; 4: 127-50
28. Prensner J R, Rubin M A, Wei J T, Chinnaiyan A M. Beyond PSA the next generation of prostate cancer biomarkers. Sci Trans Med 2012; 4: 127rv3
29. LuoM, Li Z, WangW, Zeng Y, Liu Z, Qiu J. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett 2013; 333: 213-21
30. Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J, Fang G. Upregulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J 2012; 279 (17): 3159-65
31. Sun H, Wang G, Peng Y et al. H19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cells. Oncol Rep 2015; 33 (6): 3045-52
32. Medrzycki M, Zhang Y, Zhang W et al. Histone H1. suppresses H19 noncoding RNA expression and cell growth of ovarian cancer cells. Cancer Res 2014; 74 (22): 6463-73
33. Matouk I, Ohana P, Ayesh S et al. The Oncofetal H19 RNA in human cancer, from the bench to the patient review article. Cancer Therapy 2005; 3: 249-66
34. Lin M, Wu J, Shan G. Noncoding RNAs: different roles in tumorigenesis. Chin Sci Bull 2012; 57 (9): 959-65
35. Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosys 2012; 8 (9): 2289-94
36. Matouk I J, DeGroot N, Mezan S et al. The H19 non-coding RNA is essential for human tumor growth. PLoS One 2007; 2 (9): e845
37. Georgia S, Soliz R, Li M, Zhang P, Bhushan A. p57 and Hes1 coordinate cell cycle exit with self-renewal of pancreatic progenitors. Dev Biol 2006;298 (1): 22-31
38. Liu J, Kahri AI, Heikkilä P, Voutilainen R. Ribonucleic acid expression of the clustered imprinted in adrenal tumors and cultured adrenal cells. Endocrinol Metab 1997; 82 (6): 1766-71
39. Sakai K, Peraud A, Mainprize T et al. Inducible expression of p57KIP2 inhibits glioma cell motility and invasion. J Neurooncol 2004; 68 (3): 217-23
40. Li J Q, Wu F, UsukiHet al. Loss of p57KIP2 is associated with colorectal carcinogenesis. Int J Oncol 2003; 23 (6): 1537-43
41. Luo M, Li Z, Wang W et al. Long non-coding rna h19 increases bladder cancer metastasis by associating with ezh2 and inhibiting e-cadherin expression. Cancer Lett 2013, 333: 213-21
42. Liu L, Xu Z, Zhong L et al. Enhancer of zeste homolog 2 (ezh2) promotes tumour cell migration and invasion via epigenetic repression of e-cadherin in renal cell carcinoma. BJU Int 2016; 117 (2): 351-62
43. Guo J, Cai J, Yu L et al. Ezh2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo. Cancer Sci 2011, 102: 530-39